Product Information
ARIPIPRAZOLE 30 MG TABLET is a generic product labeled by Macleods Pharmaceuticals Limited, priced at $0.1834 per EA under NDC 33342012707. Its NADAC has been published 419 times since May 10, 2017.
Strength
30 mg/1
Manufacturer
Macleods Pharmaceuticals LimitedNDC
33342012707
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
4/23/2025
Active Ingredients
ARIPIPRAZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA204111On Market Since
10/8/2016
Pharmacological Classes
Price Statistics
The NADAC for ARIPIPRAZOLE 30 MG TABLET has been published 419 times since May 10, 2017, and over the history we have for it it has declined 89.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1834 per EA |
|---|---|
| All-time high | $1.7349 (May 10, 2017) |
| All-time low | $0.1365 (Nov 20, 2024) |
| Median price | $0.3026 |
| Average price | $0.4130 |
| Largest weekly change | +41.4% (Aug 21, 2024) |
| Weeks tracked | 419 |
| Tracking since | May 10, 2017 |
Generic Alternatives
The matcher finds 13 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 9% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ARIPIPRAZOLE 30 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ARIPIPRAZOLE 30 MG TABLET, manufactured by Macleods Pharmaceuticals Limited, is $0.1834 per EA (NDC 33342012707), effective May 14, 2025.
How has the price of ARIPIPRAZOLE 30 MG TABLET changed over time?
Over the history we have for it, the NADAC for ARIPIPRAZOLE 30 MG TABLET has declined 89.4%. It has been tracked across 419 weekly CMS publications since May 10, 2017.
What are the highest and lowest recorded NADAC prices for ARIPIPRAZOLE 30 MG TABLET?
Since May 10, 2017, the NADAC for ARIPIPRAZOLE 30 MG TABLET has ranged from a low of $0.1365 (Nov 20, 2024) to a high of $1.7349 (May 10, 2017), with a median of $0.3026 per EA.
Are there cheaper alternatives to ARIPIPRAZOLE 30 MG TABLET?
Yes. 13 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, ARIPIPRAZOLE 30 MG TABLET, is $0.1670 per EA — about 9% below ARIPIPRAZOLE 30 MG TABLET.
Who manufactures ARIPIPRAZOLE 30 MG TABLET?
ARIPIPRAZOLE 30 MG TABLET (NDC 33342012707) is labeled by Macleods Pharmaceuticals Limited, and CMS classifies it as a generic product.
Related Drugs
Same classification